Literature DB >> 9540777

Exon scrambling of MLL transcripts occur commonly and mimic partial genomic duplication of the gene.

C Caldas1, C W So, A MacGregor, A M Ford, B McDonald, L C Chan, L M Wiedemann.   

Abstract

The MLL gene is frequently rearranged in acute human leukemia of both the myeloid and lymphoid lineages. Using a sensitive reverse transcriptase-polymerase chain reaction (RT-PCR) assay, we identified several abnormally spliced transcripts in which MLL exons were joined in an order different from the genomic orientation (scrambled exons). Mis-splicing of MLL was present in both normal and malignant tissues. Although the majority of these scrambled transcripts were joined accurately at consensus splice sites, there were several examples in which the junctions of exons spliced in aberrant order were at non-consensus sites. A number of features differentiate mis-splicing of MLL from the previously described cases of scrambled exons and circular RNAs. Some scrambled transcripts appear to be present in the polyadenylated fraction of RNA. No correlation of exon scrambling with exon skipping was found, and there was no particular tendency for the exons involved to be near large introns. Our data show that splicing of MLL is extremely complex. The presence of scrambled transcripts in both normal and leukemic cells, indistinguishable from transcripts resulting from genomic MLL rearrangements, precludes the use of nested RT-PCR as a screening method for detection of tandem duplication of tandem duplication of MLL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9540777     DOI: 10.1016/s0378-1119(97)00640-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  16 in total

Review 1.  Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies.

Authors:  Luiza Handschuh
Journal:  J Oncol       Date:  2019-07-30       Impact factor: 4.375

Review 2.  Detecting circular RNAs: bioinformatic and experimental challenges.

Authors:  Linda Szabo; Julia Salzman
Journal:  Nat Rev Genet       Date:  2016-10-14       Impact factor: 53.242

3.  Functional Characterization of Novel Circular RNA Molecule, circzip-2 and Its Synthesizing Gene zip-2 in C. elegans Model of Parkinson's Disease.

Authors:  Lalit Kumar; Pooja Jadiya; Rizwanul Haque; Shikha Shukla; Aamir Nazir
Journal:  Mol Neurobiol       Date:  2018-01-23       Impact factor: 5.590

4.  Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer.

Authors:  Eric Kowarz; Jennifer Merkens; Michael Karas; Theo Dingermann; Rolf Marschalek
Journal:  Am J Blood Res       Date:  2011-04-07

Review 5.  Role of circular RNAs in brain development and CNS diseases.

Authors:  Suresh L Mehta; Robert J Dempsey; Raghu Vemuganti
Journal:  Prog Neurobiol       Date:  2020-01-10       Impact factor: 11.685

6.  Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.

Authors:  M D Megonigal; E F Rappaport; R B Wilson; D H Jones; J A Whitlock; J A Ortega; D J Slater; P C Nowell; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

7.  Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types.

Authors:  Julia Salzman; Charles Gawad; Peter Lincoln Wang; Norman Lacayo; Patrick O Brown
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

8.  Trans-splicing in Higher Eukaryotes: Implications for Cancer Development?

Authors:  Peter G Zaphiropoulos
Journal:  Front Genet       Date:  2011-12-26       Impact factor: 4.599

9.  Circular RNA is expressed across the eukaryotic tree of life.

Authors:  Peter L Wang; Yun Bao; Muh-Ching Yee; Steven P Barrett; Gregory J Hogan; Mari N Olsen; José R Dinneny; Patrick O Brown; Julia Salzman
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

Review 10.  A view of pre-mRNA splicing from RNase R resistant RNAs.

Authors:  Hitoshi Suzuki; Toshifumi Tsukahara
Journal:  Int J Mol Sci       Date:  2014-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.